BridgeBio Pharma, Inc. (BBIO) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Bridgebio Pharma, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.318 day all lines have been placed on me to prevent any background noise after the company's 00:00:05.318 -- 00:00:09.944 remarks there will be a question and answer session if you would like to ask a question 00:00:09.944 -- 00:00:14.649 please press star followed by the number one on your telephone keypad if you would like 00:00:14.649 -- 00:00:19.656 to withdraw your question please press star one again thank you before we begin i would 00:00:19.656 -- 00:00:23.701 like to remind everyone that today's call may contain forward-looking statements within 00:00:23.701 -- 00:00:28.817 the meaning of the federal securities laws including but not limited to statements about 00:00:28.817 -- 00:00:34.087 Bridge Bio's future operating and financial performance, business plans, and prospects 00:00:34.087 -- 00:00:36.030 and strategy. 00:00:36.030 -- 00:00:40.197 These statements are based on current expectations and assumptions that are subject to 00:00:40.197 -- 00:00:42.261 risks and uncertainties, 00:00:42.261 -- 00:00:46.588 which could cause actual results to differ materially from those expressed or implied 00:00:46.588 -- 00:00:49.553 in these forward-looking statements. 00:00:49.553 -- 00:00:53.891 For a discussion of these risks and uncertainties, Please refer to the disclosure in 00:00:53.891 -- 00:00:59.300 today's earnings release and BridgeBio's periodic reports and SEC filings. 00:00:59.300 -- 00:01:04.388 All statements made here are based on information available to BridgeBio 00:01:04.388 -- 00:01:09.436 as of today, and the company undertakes no obligation to update any forward-looking statements 00:01:09.436 -- 00:01:12.881 made during this call, except as required by law. 00:01:12.881 -- 00:01:18.126 With that completed, Bri...